Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income 1.21 B1.07 B1.33 B1.31 B1.61 B1.4 B 5.65 B Non-Operating Income, Total 18 M35 M55 M24 M18 M22 M 119 M Interest expense, net of interest capitalized 46 M51 M100 M100 M99 M100 M 399 M Non-Operating Income, excl. Interest Expenses -28 M-16 M-45 M-76 M-81 M-78 M -280 M Unusual income/expense —————— — Pretax income 427 M311 M311 M322 M533 M383 M 1.55 B Equity in earnings —————— — Taxes 93 M77 M82 M52 M106 M94 M 334 M Non-controlling/minority interest 3 M3 M2 M5 M1 M1 M 9 M After tax other income/expense —————— — Net income before discontinued operations 331 M231 M227 M265 M426 M288 M 1.21 B Discontinued operations —————— — Net income 331 M231 M227 M265 M426 M288 M 1.21 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 329 M228 M225 M263 M357 M279 M 1.12 B Basic earnings per share (Basic EPS) 1.160.790.680.741.270.86 3.55 Diluted earnings per share (Diluted EPS) 1.150.780.680.551.060.84 3.13 Average basic shares outstanding 283 M292 M331 M310 M331 M329 M — Diluted shares outstanding 285 M293 M332 M313 M337 M334 M — EBITDA 1.28 B1.13 B1.44 B1.45 B1.74 B1.53 B 6.15 B EBIT 1.21 B1.07 B1.33 B1.31 B1.61 B1.4 B 5.65 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 64 M61 M107 M135 M133 M128 M 503 M